Fund Holdings — Enavate Sciences GP, LLC

Total Portfolio Value
$506.78M
Total Bought
$58.80M
Total Sold
$7.25M
Net Transaction
+$51.55M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
ZENAS BIOPHARMA INC(ZBIO)3,761,3593,919,159+157,80083,502142,30528.08%+58,802
IMMUNOME INC(IMNM)4,768,5834,768,583055,840102,42920.21%+46,589
SIONNA THERAPEUTICS INC(SION)2,478,0302,478,030072,879101,94620.12%+29,067
UPSTREAM BIO INC(UPB)2,459,7032,459,703046,26766,78113.18%+20,514
COMPASS THERAPEUTICS INC(CMPX)7,788,1507,788,150027,25941,8228.25%+14,564
CAMP4 THERAPEUTICS CORP(CAMP)3,785,8023,035,825-749,97711,35718,6103.67%+7,252
BRIDGEBIO ONCOLOGY THERAPEUT(BBOT)2,626,9462,626,946030,42032,8896.49%+2,469
Page 1 of 1
Enavate Sciences GP, LLC — 13F Holdings — Q4 2025 | TickerTrail